Bioceltix

Bioceltix EBITDA per Share

The EBITDA per Share of Bioceltix (BCX.WA) as of Oct 21, 2026 is -3.28 PLN. In the previous year, EBITDA per Share was -3.71 PLN — a change of -11.46% (higher).

EBITDA per Share

-3.28PLN

YoY

-11.46%

Last updated:

EBITDA per Share of Bioceltix is 2025 -3.28 PLN. EBITDA per Share of Bioceltix was 2024 -3.71 PLN. It decreases by -11.46% higher compared to the previous year.

The Bioceltix EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
-0.35 PLN
Jan 1, 2019
-0.67 PLN
Jan 1, 2020
-0.68 PLN
Jan 1, 2021
-1.78 PLN
Jan 1, 2022
-2.69 PLN
Jan 1, 2023
-3.73 PLN
Jan 1, 2024
-3.71 PLN
Jan 1, 2025
-3.28 PLN
The Bioceltix EBITDA per Share history
YEAREBITDA per ShareYoY
-3.28PLN-11.46%
-3.71PLN-0.50%
-3.73PLN+38.38%
-2.69PLN+51.62%
-1.78PLN+160.86%
-0.68PLN+1.02%
-0.67PLN+94.16%
-0.35PLN—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Bioceltix Stock analysis

What does Bioceltix do? Bioceltix SA focuses on research and development within the field of veterinary medicine, specifically targeting the treatment of companion animals. The company develops candidates for veterinary medicinal products by utilizing the immunomodulatory properties of mesenchymal stem cells as the active substance. This scientific approach allows the firm to conduct research and development works that facilitate clinical trials and the full registration of these medicinal products with the European Medicines Agency, adhering to standards similar to those for human medicines. Bioceltix is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bioceltix stock

EBITDA per Share of Bioceltix is -3.28 PLN in 2025.

EBITDA per Share of Bioceltix changed from -3.71 PLN to -3.28 PLN, representing a -11.46% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Bioceltix since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Bioceltix

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Bioceltix